Cessation of cyclic stretch induces atrophy of C2C12 myotubes

Biochem Biophys Res Commun. 2013 May 3;434(2):316-21. doi: 10.1016/j.bbrc.2013.03.048. Epub 2013 Mar 26.

Abstract

Cyclic stretch of differentiated myotubes mimics the loading pattern of mature skeletal muscle. We tested a cell culture model of disuse atrophy by the cessation of repetitive bouts of cyclic stretch in differentiated C2C12 myotubes. Myotubes were subjected to cyclic strain (12%, 0.7 Hz, 1 h/d) on collagen-I-coated Bioflex plates using a computer-controlled vacuum stretch apparatus (Flexcell Int.) for 2 (2dSTR) or 5 (5dSTR) consecutive days. Control cultures were maintained in the Bioflex plates without cyclic stretch for 2d or 5d. Additionally, some cultures were stretched for 2 d followed by cessation of stretch for 3d (2dSTR3dCES). Cyclic stretching (5dSTR) increased myotube diameter and overall myotube area by ~2-fold (P<0.05) compared to non-stretched controls, while cessation of stretch (2dSTR3dCES) resulted in ~80% smaller myotubes than 5dSTR cells, and 40-50% smaller than non-stretched controls (P<0.05). Further, the calpain-dependent cleavage products of αII-spectrin (150 kDa) and talin increased (3.5-fold and 2.2-fold, respectively; P<0.05) in 2dSTR3dCES myotubes, compared to non-stretched controls. The 1h cyclic stretching protocol acutely increased the phosphorylation of Akt (+4.5-fold; P<0.05) and its downstream targets, FOXO3a (+4.2-fold; P<0.05) and GSK-3β (+1.8-fold; P<0.05), which returned to baseline by 48 h after cessation of stretch. Additionally, nitric oxide production increased during stretch and co-treatment with the NOS inhibitor, l-NAME, inhibited the effects of stretch and cessation of stretch. We conclude that cessation of cyclic stretching causes myotube atrophy by activating calpains and decreasing activation of Akt. Stretch-induced myotube growth, as well as activation of atrophy signaling with cessation of stretch, are dependent on NOS activity.

MeSH terms

  • Animals
  • Biomechanical Phenomena
  • Cell Differentiation
  • Cell Line, Tumor
  • Cell Membrane / enzymology
  • Cell Membrane / metabolism
  • Cell Size
  • Cytoplasm / enzymology
  • Cytoplasm / metabolism
  • Enzyme Activation
  • Forkhead Box Protein O3
  • Forkhead Transcription Factors / metabolism
  • Immunohistochemistry
  • Mice
  • Muscle Fibers, Skeletal / enzymology
  • Muscle Fibers, Skeletal / metabolism
  • Muscle Fibers, Skeletal / pathology*
  • Muscle Tonus*
  • Muscular Atrophy / metabolism
  • Muscular Atrophy / pathology*
  • Myosin Heavy Chains / metabolism
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type I / antagonists & inhibitors
  • Nitric Oxide Synthase Type I / metabolism
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / metabolism
  • Nonmuscle Myosin Type IIA / metabolism
  • Phosphorylation
  • Proteolysis
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction
  • Stress, Mechanical*
  • Time Factors

Substances

  • Forkhead Box Protein O3
  • Forkhead Transcription Factors
  • FoxO3 protein, mouse
  • Nitric Oxide
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type II
  • Proto-Oncogene Proteins c-akt
  • Nonmuscle Myosin Type IIA
  • Myosin Heavy Chains
  • NG-Nitroarginine Methyl Ester